We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

How CRISPR Is Transforming High-Throughput Screening content piece image
Industry Insight

How CRISPR Is Transforming High-Throughput Screening

This article walks through the fundamentals of CRISPR screening and its most exciting applications, including unpicking cellular signaling networks, discovering how viruses like COVID-19 infect our cells and finding new drug targets.
One-Chip-Fits-All: Biofabrication of Hydrogel Fiber Architectures Using Flow Focusing Microfluidics content piece image
Industry Insight

One-Chip-Fits-All: Biofabrication of Hydrogel Fiber Architectures Using Flow Focusing Microfluidics

This article discusses an innovative biofabrication method that uses a single 3D hydrodynamic flow focusing chip to generate different hydrogel configurations with specific geometries for various biological applications.
“Rewriting the Textbook” for Precision Medicine content piece image
Industry Insight

“Rewriting the Textbook” for Precision Medicine

Technology Networks recently had the pleasure of speaking with Mark Fidock, vice president for Diagnostic Development, Precision Medicine at AstraZeneca, to find out how the company is “rising to the challenge” of delivering precision medicines for chronic diseases.
Measuring Temperature Performance for Reliable Vaccine Storage content piece image
Industry Insight

Measuring Temperature Performance for Reliable Vaccine Storage

Technology Networks recently spoke to Drew Buskirk to learn more about peak variation and why it is so important to measure.
Meet the Scientists Bringing Back the Extinct Tasmanian Tiger content piece image
Industry Insight

Meet the Scientists Bringing Back the Extinct Tasmanian Tiger

The biotech/genetic engineering company Colossal – co-founded in 2021 by renowned geneticist Professor George Church and serial entrepreneur Ben Lamm – announced it has begun a de-extinction project of the thylacine – an Australian marsupial commonly referred to as the “Tasmanian tiger”. Technology Networks interviewed the team to learn more.
 Machine Learning Helps Achieve Greater Depth in Proteome Analysis    content piece image
Industry Insight

Machine Learning Helps Achieve Greater Depth in Proteome Analysis

To understand how machine learning methods and new software capabilities are helping proteomics researchers gain greater depth in their analyses, Technology Networks recently interviewed Tharan Srikumar, product manager in bioinformatics at Bruker Daltonics.
Exploring Flow Electroporation for Cell Engineering content piece image
Industry Insight

Exploring Flow Electroporation for Cell Engineering

Technology Networks spoke to Dr. Cenk Sumen, chief scientific officer of MaxCyte, about their pioneering cell engineering platform.
Combining Coding and Biology To Engineer Human Cells content piece image
Industry Insight

Combining Coding and Biology To Engineer Human Cells

To learn more about new technologies being developed for drug discovery and cell therapy, Technology Networks spoke to bit.bio's Dr. Farah Patell-Socha and Furqan Iqbal.

Bridging the Gap Between <i>In Vitro</i> and Animal Models of Liver Disease content piece image
Industry Insight

Bridging the Gap Between In Vitro and Animal Models of Liver Disease

We spoke to Dr. Audrey Dubourg, product manager at CN Bio to find out more about how its organ-on-chip platform could bridge the gap between the current 2D models and animal models, providing human-relevant insights into diseases such as non-alcoholic steatohepatitis.
Alzheimer’s Breakthrough: A Disruptive Systemic Approach Is Poised To Demonstrate Value content piece image
Industry Insight

Alzheimer’s Breakthrough: A Disruptive Systemic Approach Is Poised To Demonstrate Value

Today’s treatments for AD are limited and unsatisfactory. This article explores a drug development effort that is taking a completely different approach – not trying to cure the disease but actually repair the damage.
Advertisement